switching from semaglutide to liraglutide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Liraglutide vs. Semaglutide: What is

Stereociliary anomaly in the guinea pig: effects of hair bundle rotation on cochlear sensitivity

f , SDS-PAGE immunoblot of complex I and II subunits in isolated gWAT mitochondria from Control and NDI1 mice after 10 weeks of HFD feeding (n = 6)

doi:10.1056/NEJMoa2032183 Marso SP, Bain SC, Consoli A, et al

Wendisch, [email protected] This article was submitted to Industrial Biotechnology, a section of the journal Frontiers in Bioengineering and Biotechnology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers